Bipolar Disorder Market Size, Share, Growth Analysis, By Drug Class(Mood Stabilizers, Anticonvulsants, Antipsychotic Drugs, Antidepressant Drugs), By Type(Bipolar I Disorder, Bipolar II Disorder, Cyclothymic Disorder, Others), By Region - Industry Forecast 2024-2031

Bipolar Disorder Market size was valued at USD 5.25 billion in 2019 and is poised to grow from USD 5.36 billion in 2023 to USD 6.4 billion by 2031, growing at a CAGR of 2.00% in the forecast period (2024-2031).

Manic depression, formerly known as bipolar disorder is a mental health illness that results in sharp mood swings, including emotional highs (mania or hypomania), and lows (depression). According to research, the fact that bipolar disorder frequently runs in families and that some people are more predisposed to the condition than others due to certain genes. No single gene can cause the condition; multiple genes are involved.

Three distinct diagnoses fall under the category of bipolar disorder bipolar I, bipolar II, and cyclothymic disorder. According to a recent study, India has the lowest lifetime risk of bipolar disorder at 0.1% and the United States has the highest rate at 4.4%.

A few of the factors boosting the growth of this market include the rising prevalence of bipolar illness, government assistance for raising awareness about the condition, and technology advancements that enable precise detection of a patient's mood and mental state. In contrast to other medications used to treat bipolar disorder, the use of tricyclic antidepressants has decreased over time as a result of their higher prevalence of side effects.

US Bipolar Disorder Market  is poised to grow at a sustainable CAGR for the next forecast year.